Resultados de la búsqueda 121-130 of 13025 for B cell lymphomas
... B cell lymphoma (DLBCL) after receiving at least two lines of therapy. Additional cohorts include subjects with B-cell primary or secondary central nervous ...
The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss · A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B ...
... B-cell non-Hodgkin lymphoma. A Study To Evaluate Regulation Of The Metabolism Of T-Cells By The Tumor Microenvironment In Ovarian Cancer Metastasis.
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study Of CA-4948 In Patients With ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Study Of 177Lu-FAP-2286 In Advanced Solid Tumors. Jacksonville, Fla., Rochester, Minn. Fibroblast activation protein ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?